543
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Remission of De Novo Membranous Nephropathy in a Kidney Allograft Recipient: a Case Report

, , , &
Pages 1341-1343 | Received 08 Jun 2012, Accepted 24 Jul 2012, Published online: 25 Sep 2012

REFERENCES

  • Schwarz A, Krause PH, Offermann G, Keller F. Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation. Transplantation. 1994; 58(6):650–654.
  • Hariharan S, Adams MB, Brennan DC, . Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry (RADR) Transplantation. 1999;68(5):635–641.
  • Honda K, Horita S, Toki D, . De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney. Clin Transplant. 2011;25(2):191–200.
  • Morales JM, Pascual-Capdevila J, Campistol JM, . Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation. 1997;63(11):1634–1639.
  • Aline-Fardin A, Rifle G, Martin L, . Recurrent and de novo membranous glomerulopathy after kidney transplantation. Transplant Proc. 2009;41(2):669–671.
  • Berger BE, Vincenti F, Biava C, Amend WJJr, Feduska N, Salvatierra OJr. De novo and recurrent membranous glomerulopathy following kidney transplantation. Transplantation. 1983;35(4):315–319.
  • El Kossi M, Harmer A, Goodwin J, . De novo membranous nephropathy associated with donor-specific alloantibody. Clin Transplant. 2008;22(1):124–127.
  • Schwarz A, Krause PH, Offermann G, Keller F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis. 1991;17(5): 524–531.
  • Gallon L, Chhabra D. Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient. Am J Transplant. 2006;6(12):3017–3021.
  • Weclawiak H, Ribes D, Guilbeau-Frugier C, . Relapse of membranous glomerulopathy after kidney transplantation: Sustained remittance induced by rituximab. Clin Nephrol. 2008;69(5):373–376.
  • Ideura T, Hora K, Kaneko Y, et al. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: A case report. Transplant Proc. 2000;32(1):223–226.
  • Poduval RD, Josephson MA, Javaid B. Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol. 2003;23(4):392–399.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.